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Definition
• Acute Rheumatic Fever (ARF) is an illness 
caused by an immunological reaction to 
infection with the bacterium group A 
streptococcus (GAS). It causes an acute, 
generalised inflammatory response, and is 
an illness that affects only certain parts of 
the body, mainly the heart, joints, brain and 
skin. 
RHDAustralia (ARF/RHD writing group), National Heart Foundation of Australia and 
the Cardiac Society of Australia and New Zealand.
Australian guideline for prevention, diagnosis and management of acute rheumatic 
fever and rheumatic heart disease (2nd edition). 2012
Classification (WHO Expert Consultation: 
rheumatic fever  and rheumatic heart disease, 
2004) 
• Primary episode of ARF: a patient without a prior episode of 
rheumatic fever and without evidence of established rheumatic 
heart disease presents with a clinical illness that meets the 
requirements of the Jones criteria for diagnosis of ARF
• Recurrent episode of ARF: a patient who has had documented 
rheumatic fever in the past, but without evidence of established 
rheumatic heart disease, who presents with a new clinical illness 
that meets the requirements of the Jones criteria for diagnosis of 
ARF
• Recurrent episode of ARF in patients with rheumatic heart 
disease: a patient who has evidence of established rheumatic 
heart disease, who presents with a new clinical illness that meets 
the requirements of the Jones criteria for diagnosis of ARF
World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation. 2004
Epidemiology
Primary episodes of acute rheumatic fever 
• occur mainly in 5-15 yrs
• rare <3 yrs and > 30 yrs old
• girls>boys
• Environmental factors-- over crowding, 
poor sanitation, poverty
• Incidence more during fall ,winter & 
early spring
Global prevalence of rheumatic 
heart disease in children aged 5 
to 14 years.
Lancet Infect Dis. 2005;5:685-694
The greatest 
burden of acute 
rheumatic fever and 
rheumatic heart 
disease is in people 
in developing 
countries and in 
populations of 
indigenous people 
living in poverty in 
industrialised 
countries
Etiopathogenesis
• Acute rheumatic fever is a hypersensitivity reaction 
induced by group A streptococci.
• Antibodies against M proteins of certain  strains of 
streptococci cross react with antigens in heart, joints 
and other tissues.
• Genetic susceptibility is suggested
• Autoimmune response to self antigens also suggested.
• Chronic sequelae are a result of progressive fibrosis 
(healing process) and blood turbulance in valvular areas
Proposed pathological mechanism of 
valvular inflammation in ARF 
Steer AC, Carapetis JR. Encyclopedia of Molecular Mechanisms of Disease. (Publication date April 2009.) 
• Strains that produces rheumatic fever -
M types l, 3, 5, 6,18  & 24
• Pharyngitis- produced by GABHS  can 
lead to- acute rheumatic fever ,
rheumatic heart disease & 
post strept. Glomerulonepritis
• Skin infection- produced by GABHS leads 
to post streptococcal glomerulonephritis
only. It will not result in  Rh.Fever or 
carditis as skin lipid cholesterol inhibit 
antigenicity
Group A Beta Hemolytic Streptococcus
Pathologic Lesions
• Fibrinoid degeneration of connective 
tissue,inflammatory edema, inflammatory cell 
infiltration &  proliferation of specific cells 
resulting in formation of  Ashcoff nodules, 
resulting in-
-Pancarditis in the heart
-Arthritis in the joints
-Ashcoff nodules in the subcutaneous 
tissue
-Basal gangliar lesions resulting in 
chorea
Key diagnostic factors of ARF
Fever 
• Common
• Occurs in nearly all cases at the onset of 
the illness. 
• Historically, most cases will have fever 
above 39°C (102.2°F), but many experts 
suggest that 38°C (100.4°F) measured 
orally, rectally, or tympanic is significant.
Recent sore throat or scarlet 
fever 
• common
• may suggest recent group A streptococcal 
infection
Arthritis
• The most common manifestation, present in 60-80% 
of patients
• In addition to arthralgia, the joints are red, warm and 
swollen. 
• Arthritis is characteristically asymmetrical, migratory, 
and very painful, although some patients may present 
mild joint complaints.
• It usually resolves spontaneously in 2- 3 weeks. 
• Commonly involved joints: knee, ankle, elbow & wrist
• An excellent response to salicylates. 
• Arthritis do not progress to chronic disease
Arthritis
• asymmetrical,  red, warm 
and swollen.
accessmedicine.mhmedical.com
Arthritis
• If the patient has monoarthritis and is suspected to 
have ARF, but does not meet the criteria for diagnosis, 
the patient should withhold from treatment with 
NSAIDs so that the appearance of migratory 
polyarthritis (a major manifestation) is not masked.
• The arthritis of ARF is very sensitive to salicylates 
such as aspirin (as well as other NSAIDs), and if joint 
symptoms do not respond within 1 to 2 days of 
treatment with these anti-inflammatory drugs, the 
diagnosis should be reconsidered.
Carditis
Rheumatic inflammation in the heart may 
affect 
• the pericardium (often asymptomatic),
• the myocardium (rarely contributes to 
cardiac failure), 
• or the endocardium (the most common 
and the most important [i.e., the valvular
tissue]). 
• granulomatous inflammation manifests in 
the myocardium as Aschoff bodies
Carditis: Aschoff bodies
These may disrupt the electrical conduction pathways 
leading to prolongation of the PR interval on 
electrocardiogram
Aschoff bodies
consist of fibrinoid
change in
connective tissue,
lymphocytes,
occasional plasma
cells, and
abnormal
characteristic
histiocytes.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232519/figure/F3/
Clinical Features: Carditis
• Manifest as pancarditis(endocarditis, 
myocarditis and pericarditis),occur in  40-
50% of cases
• Carditis is the only manifestation of 
rheumatic fever that leaves a sequelae & 
permanent damage to the organ
• Valvulitis occur in acute phase
• Chronic phase- fibrosis,calcification & 
stenosis of heart valves(fishmouth valves)
• Mitral valve is most often affected with 
rheumatic heart disease, followed by 
mitral and aortic together, then aortic 
alone, then mitral, aortic, and tricuspid 
together.
• Mitral stenosis (99% cases) as a result 
of calcification.
Carditis
Rheumatic 
heart 
disease. 
Abnormal 
mitral 
valve. 
Thick, 
fused 
chordae
www.cram.com
Mitral valve in chronic rheumatic 
heart disease
• Mitral valve as seen 
from above in the left 
atrium.
• Typical "fish mouth" 
shape with chronic 
rheumatic scarring. 
Also buttonhole 
stenosis may occur
library.med.utah.edu
Stenotic mitral valve seen from left atrium. Both 
commissures are fused; the cusps are severely 
thickened. The left atrium is huge. The valve is 
both incompetent and stenotic
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232519/figure/F8/
• The clinical picture includes high pulse rate, congestive 
heart failure, arrhytmias and pericardial friction rubs. 
• On the first attack, valvulitis is suspected in the presence 
of a new apical systolic murmur of mitral regurgitation 
(associated or not with an apical mid-diastolic murmur) 
and/or a basal diastolic murmur of aortic regurgitation. 
• Cardiomegaly is noted on X-Ray and on echocardiogram.
• Myocarditis and/or pericarditis in the absence of valvular 
involvement is unlikely due to acute RF. It is contentious if 
myocardial disfunction in acute RF is valvular or 
myocardial in origin.
• In a subset of patients, the initial presentation may be 
quite severe, with overt heart failure, fever and toxaemia, 
making the differential diagnosis with infective 
endocarditis very difficult, in particular in patients with 
recurrent rheumatic heart disease
Carditis
Sydenham Chorea
• Occurs in 5-10% of cases
• Mainly in girls of 1-15 yrs age
• It is  often the sole manifestation of ARF: 
• It is usually a delayed manifestation: typically affects pts 
after a latency period of up to 6 months after group A 
streptococcal infection
• Involuntary movements, specially of the face and limbs, 
muscle weakness, disturbances of speech and gait.
• Chorea always disappears with sleep, and is made more 
pronounced by purposeful movements
• Children usually exhibit concomitant psychologic 
dysfunction, especially obsessive-compulsive disorder, 
increased emotional lability, hyperactivity, irritability and 
age-regressed behavior.
web.stanford.edu
Sydenham Chorea
• Restlessness 
• Clumsiness 
• Emotional lability and personality changes 
• Jerky, uncoordinated choreiform movements
• Inability to maintain protrusion of the tongue (chorea 
affecting the tongue). May resemble a 'bag of worms' when 
protruded.
• Milkmaid's grip. Rhythmic squeezing when the patient 
grasps the examiner's hands, 
• Spooning sign . Flexion of the wrists and extension of the 
fingers when the hands are extended, seen with chorea.
• Pronator sign. Turning outwards of the arms and palms 
when held above the head, seen with chorea.
Sydenham Chorea
•involuntary movements, 
especially of the 
face and limbs, 
•muscle weakness,
www.healthandfitnesstalk.com
Erythema Marginatum
• Occurs in <5%.
• Evanescent, erythematous, non-pruritic 
rash with pale centers and rounded or 
serpiginous margins of 1-2 inches in 
size. 
• Occur mainly on the trunk and proximal 
extremities and may be induced by 
application of heat.
• Often associated with chronic carditis
Erythema Marginatum
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232519/figure/F12/
Erythema Marginatum
• The rash may appear and then disappear 
before the examiner's eyes, leading to the 
descriptive term of patients having 'smoke 
rings' beneath the skin. 
• Usually appears during the acute phase of 
rheumatic fever but may recur for weeks 
or even months after the acute phase has 
subsided. 
• May be difficult to detect in dark-skinned 
people.
Subcutaneous nodules
• Rare, occurring in <5% of cases
• Always associated with severe carditis
• Painless, pea-sized, palpable firm, movable, 
measuring around 0.5 to 2 cm nodules
• Mainly over extensor surfaces of joints (particularly 
knees, wrists and elbows), or bony protuberances 
(spine, scapulae & scalp)
• Associated with strong seropositivity
• Often appear after the onset of acute rheumatic 
fever and last from a few days to 3 weeks.
Subcutaneous nodules
Painless, pea-sized, palpable nodule
over extensor surface of the elbow
https://www.google.com.ua/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0CAYQjB1qFQoTCJW8pKzr5cgCFWNwcgodevwGlA&url=http%3A%2F%2Fwww.slideshare.net%
2Fazadhaleem%2Frheumatic-fever-46427613&psig=AFQjCNFacKKDbfftLtAmvM06qmPLnJrS_A&ust=1446144594193191
Subcutaneous nodule on the extensor surface of 
elbow of a patient with acute RF
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232519/figure/F11/
With the exception of Sydenham’s chorea, which has a latency 
period of several months, the clinical manifestations of acute 
RF present after about 3 weeks following the streptococcal 
throat infection emedicine.medscape.com
Laboratory Findings
• High ESR
• Anemia, leucocytosis (rare!)
• Elevated C-reactive protein
• Elevated ASO titer (The test specificity has 
been shown to be 93% with ASO titers above 
960 IU/ml)
– Peak value attained at 3 weeks,then comes down 
to normal by 6 weeks
• Anti-DNAse B test
• Throat culture-GABH streptococci (prior to 
antibiotic therapy to culture for group A Streptococcus. Less 
than 10% are positive, reflecting the post-infectious nature of 
the disease)
Laboratory Findings (Contd)
• Chest X-ray
• ECG- prolonged PR interval, 2nd or 3rd 
degree blocks, ST depression,   T 
inversion
• 2D Echo cardiography- valve edema,mitral 
regurgitation, LA & LV dilatation,pericardial 
effusion,decreased contractility
Chest radiograph of an 8 year old patient 
with acute carditis before treatment 
b: Same patient after 4 weeks
http://www.ncbi.nlm.nih.gov/pmc/articles/P
MC3232519/figure/F4/
ECG showing heart block in 
ARF
Aust N Z J Med. 1996;26:241-242.
Two-dimensional parasternal long-axis view of a
patient with mitral stenosis, showing thickened valve
cusps (arrow), with poor leaflet separation in diastole.
Left atrium is enlarged, with a thrombus in the
posterior aspect of it. Aortic valve is also stenotic
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232519/figure/F7/
www.oocities.org
Diagnosis
• Rheumatic fever is mainly  a clinical 
diagnosis
• No single diagnostic sign or specific 
laboratory test available for diagnosis
• Diagnosis based on MODIFIED JONES 
CRITERIA , the latest revision of the 
Jones criteria were published in 2015
Revised Jones criteria, 2015
1. Two separate sets of criteria: 
• low-risk settings (i.e., those with a rheumatic fever 
incidence ≤2 per 100,000 school-aged children or all-age 
rheumatic heart disease prevalence ≤1 per 1000 
population per year)
• moderate- to high-risk populations
2. The diagnosis of possible rheumatic fever. 
This category of diagnosis allows for the situation when a 
given clinical presentation may not fulfil the revised Jones 
criteria but the clinician may still have good reason to suspect 
the diagnosis.
Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones criteria for the diagnosis 
of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement 
from the American Heart Association. Circulation. 2015;131:1806-1818.
The diagnosis of a primary 
episode of ARF 
Any of the following criteria are met.
• Evidence of a recent group A streptococcal infection with 
at least 2 major manifestations or 1 major plus 2 minor 
manifestations present.
• Rheumatic chorea: can be diagnosed without the 
presence of other features and without evidence of preceding 
streptococcal infection. It can occur up to 6 months after the 
initial infection.
• Chronic rheumatic heart disease: established mitral valve 
disease or mixed mitral/aortic valve disease, presenting for the 
first time (in the absence of any symptoms suggestive of acute 
rheumatic fever).
Evidence of antecedent group A 
streptococcal infection 
1 of the following:
• Elevated or rising streptococcal 
antibody titre
• Positive throat culture
• Positive rapid antigen test for group A 
streptococci
• Recent scarlet fever.
Major manifestations of ARF:
1. Carditis: includes carditis demonstrated only by 
echocardiogram (i.e., subclinical carditis).
2. Arthritis: polyarthritis (low-risk populations) or 
monoarthritis or polyarthritis or polyarthralgia 
(moderate- to high-risk populations).
3. Chorea.
4. Erythema marginatum: 
5. Subcutaneous nodules.
Minor manifestations of ARF
1. Fever: ≥38.5°C (≥101.3°F; low-risk populations) or ≥38.0°C 
(≥100.4°F; moderate- to high-risk populations
2. Arthralgia: polyarthralgia (low-risk populations) or 
monoarthralgia (moderate- to high-risk populations)
3. Elevated inflammatory markers: ESR ≥60 mm/hour and/or 
CRP ≥28.57 nanomols/L (≥3.0 mg/dL) (low-risk populations) 
or ESR ≥30 mm/hour and/or CRP ≥28.57 nanomols/L (≥3.0 
mg/dL) (moderate- to high-risk populations)
4. Prolonged PR interval on ECG: a prolonged PR interval that 
resolves over 2 to 3 weeks may be a useful diagnostic feature 
in cases when clinical features are not definitive. First-degree 
heart block sometimes leads to a junctional rhythm. Second-
degree and even complete block are less common but can 
occur
Major and minor manifestations 
of ARF
• in a patient in whom arthritis is considered 
a major manifestation, arthralgia cannot be 
counted as a minor manifestation
• in a patient in whom carditis is considered 
as a major manifestation, a prolonged PR 
interval cannot be counted as a minor 
manifestation
Diagnosing recurrent rheumatic 
fever
Recurrence of rheumatic fever, with or 
without evidence of established rheumatic 
heart disease, requires 
• the same criteria as a primary episode. 
(i.e., 2 major manifestations, or 1 major 
plus 2 minor manifestations) or
• the presence of 3 minor manifestations. 
Diagnosis of recurrence requires evidence 
of a recent group A streptococcal infection
Treatment
Step I - primary prevention 
(eradication of streptococci)
Step II - anti inflammatory treatment 
(aspirin,steroids)
Step III- supportive management & 
management of complications
Step IV- secondary prevention 
(prevention of recurrent attacks)
THIS IS TOO 
LATE
STEP I: Primary Prevention of ARF (Treatment of 
Streptococcal Tonsillopharyngitis) 
Primary options
• phenoxymethylpenicillin potassium: children ≤27 kg: 250 mg 
orally two to three times daily for 10 days; children >27 kg and 
adults: 500 mg orally two to three times daily for 10 days
• benzathine benzylpenicillin: children ≤27 kg: 600,000 units 
intramuscularly as a single dose; children >27 kg and adults: 
1.2 million units intramuscularly as a single dose
• amoxicillin: children: 50 mg/kg/day orally given in 2 divided 
doses for 10 days, maximum 1000 mg/day; adults: 875 mg 
orally twice daily for 10 days
Secondary options
• azithromycin: adults: 500 mg orally once daily for 5 days
• clarithromycin: adults: 250 mg orally twice daily for 10 
days
• erythromycin base: adults: 250-500 mg orally four times 
daily for 10 days
• cephalexin: adults: 500 mg orally twice daily for 10 days
• cefadroxil: adults: 1000 mg/day orally given in 1-2 divided 
doses for 10 days
• clindamycin: adults: 300-600 mg orally every 8 hours for 
10 days
STEP I: Primary Prevention of ARF (Treatment 
of Streptococcal Tonsillopharyngitis) 
NSAIDs – if arthritis is present
Primary options
• aspirin: adults: 4000 mg/day orally given in 
divided doses every 4-6 hours
Secondary options
• naproxen: adults: 250-500 mg orally twice 
daily, maximum 1250 mg/day
• ibuprofen: adults 400-800 mg orally three 
times daily, maximum 2400 mg/day
Step II: Anti inflammatory treatment
Glucocorticoids (GCSs)
• Most patients with mild or moderate carditis without 
cardiac failure do not require any therapy.
• A subset of patients with carditis who have cardiac 
failure do require treatment. The side effects of GCSs 
include gastrointestinal bleeding and fluid retention, both 
of which can worsen heart failure.
• Concurrent administration of ranitidine (or PPI) should be 
considered to reduce the risk of gastrointestinal 
bleeding.
Step II: Anti inflammatory treatment
Glucocorticoids (GCSs)
• GCSa will usually also control joint pain and fever, and 
so aspirin can be discontinued while the patient is being 
treated with GCSs; aspirin may need to be restarted 
after the patient completes the course of glucocorticoid 
treatment, particularly if this course is short.
• If more than 1 week of treatment is required, taper by 
20% to 25% each week.
Step II: Anti inflammatory treatment
Glucocorticoids (GCSs)
Primary options
• prednisolone: children and adults: 1-2 mg/kg/day orally 
for 7 days, maximum 80 mg/day
• methylprednisolone: children and adults: 24 mg orally 
once daily for 7 days
Step II: Anti inflammatory treatment
• Bed rest 
• Treatment of congestive cardiac failure
• Treatment of chorea
• Rest to joints & supportive splinting
Step III: Supportive management & 
management of complications
The WHO defines secondary prophylaxis 
for rheumatic fever as "the continuous 
administration of specific antibiotics to 
patients with a previous attack of rheumatic 
fever, or well-documented rheumatic heart 
disease. The purpose is to prevent 
colonisation or infection of the upper 
respiratory tract with group A streptococci 
and the development of recurrent attacks of 
rheumatic fever”
STEP IV : Secondary 
Prevention of Rheumatic Fever 
Duration of secondary 
prophylaxis 
World Health Organization. WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart 
Disease. Geneva: World Health Organization; 2004
Antibiotics used in secondary 
prophylaxis of RF (from WHO Technical 
Report on RF and RHD 2004)
WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. 
Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, 
29 October - 1 November 2001. Geneva; 2004
Prognosis
• Rheumatic fever can recur whenever the 
individual experience new GABH 
streptococcal infection,if not on 
prophylactic medicines
• Good prognosis for older age group & if no 
carditis during the initial attack
• Bad prognosis for younger children & 
those with carditis with valvar lesions
Summary
• ARF continues to cause a large burden of 
mortality and morbidity in developing countries. It is less 
common in developed countries but continues to be 
seen in indigenous communities and during outbreaks.
• It is caused by an autoimmune process following 
infection with group A streptococci.
• No single test can diagnose acute rheumatic fever. 
Diagnosis is clinical and relies on the Jones criteria.
• The 5 major manifestations of acute rheumatic 
fever are carditis, arthritis, chorea, erythema 
marginatum, and subcutaneous nodules, of which the 
most common are carditis and arthritis.
Summary (cont’d)
• The Jones criteria were revised in 2015 to include 
separate criteria for low-risk and moderate- to high-
risk populations.
• While all other manifestations of acute rheumatic 
fever resolve without sequelae, carditis can lead to 
chronic rheumatic heart disease.
• No treatment has been shown to alter the 
progression of acute rheumatic fever to chronic 
rheumatic heart disease.
• Secondary prophylaxis can improve the 
prognosis of established rheumatic valvular disease.
